Speciality: Oncology
Description:
Welcome to our special feature on relapsed B-cell Acute Lymphoblastic Leukemia (B-cell ALL) in adults. Join leading experts Dr. Riyaz Ahmad, Dr. Nitin Gupta, and Dr. Eesha Kaul as they explore the latest breakthroughs in treating this aggressive form of leukemia. With years of experience in hematology and oncology, they bring valuable insights into how modern medicine is reshaping the outlook for adult patients.
In this video, our experts discuss the challenges of relapsed B-cell ALL and how innovative treatments like CAR T-cell therapy, blinatumomab, and inotuzumab ozogamicin are offering new hope. They highlight the importance of precision medicine, the evolving role of stem cell transplantation, and the need for holistic care in improving outcomes and quality of life for patients.
Thank you for watching. We hope this video offers clarity and encouragement to patients, families, and healthcare professionals. Don’t forget to like, share, and follow our channel for more updates on cutting-edge treatments and expert perspectives in cancer care.
See More Webinars @ Hidoc Webinars
1.
"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.
2.
Recently released national data on drug use and abuse among Americans.
3.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
4.
Ketamine plus psychotherapy for "excellent" PTSD
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Personalized Tumor Ecological Landscapes in Oncology
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
Preserving Social Identity During Cancer Survivorship
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Regenerative Models of Tumor Microenvironments: Clinical Relevance and Emerging Insights
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
From Guidelines to Practice: Hematology
5.
Breast Cancer Awareness and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation